A case of the Pfizer-BioNTech vaccine waits to be administered, during the start of the Covid-19 vaccination campaign in Overijse, Belgium.(AP)
A case of the Pfizer-BioNTech vaccine waits to be administered, during the start of the Covid-19 vaccination campaign in Overijse, Belgium.(AP)

Rich nations stockpiling a billion more Covid-19 shots than needed: Report

The report looked specifically at contracts with the five leading Covid-19 vaccine makers - Pfizer-BioNTech, Moderna, Oxford-AstraZeneca, Johnson & Johnson, and Novavax.
Reuters |
PUBLISHED ON FEB 19, 2021 07:03 AM IST

Rich countries are on course to have over a billion more doses of Covid-19 vaccines than they need, leaving poorer nations scrambling for leftover supplies as the world seeks to curb the coronavirus pandemic, a report by anti-poverty campaigners found on Friday.

In an analysis of current supply deals for Covid-19 vaccines, the ONE Campaign said wealthy countries, such as the United States and Britain, should share the excess doses to "supercharge" a fully global response to the pandemic.

The advocacy group, which campaigns against poverty and preventable diseases, said a failure to do so would deny billions of people essential protection from the Covid-19-causing virus and likely prolong the pandemic.

The report looked specifically at contracts with the five leading Covid-19 vaccine makers - Pfizer-BioNTech, Moderna, Oxford-AstraZeneca, Johnson & Johnson, and Novavax.

It found that to date, the United States, the European Union, Britain, Australia, Canada and Japan have already secured more than 3 billion doses - over a billion more than the 2.06 billion needed to give their entire populations two doses.

Also read| Harris taps growing political power of women lawmakers; promotes Covid-19 relief

"This huge excess is the embodiment of vaccine nationalism," said Jenny Ottenhoff, ONE Campaign's senior director for policy. "Rich countries understandably hedged their bets on vaccines early in the pandemic but with these bets paying off in spades, a massive course correction is needed if we are going to protect billions of people around the world," she added.

The analysis found that, along with other Covid vaccine supplies procured by the global COVAX vaccine-sharing plan and in bilateral deals, the excess rich-country doses would go a long way to protecting vulnerable people in poorer countries.

This would significantly reduce the risk of deaths from Covid-19, it said, as well as limiting the chances of new virus variants emerging and accelerating an end to the pandemic.

The World Health Organization on Thursday urged nations with vaccines not to share them unilaterally, but to donate them to the global COVAX scheme to ensure fairness. The One Campaign report found that with current supply deals, Australia, Canada, US, UK and European states would be available to share Covid-19 vaccines.

This story has been published from a wire agency feed without modifications to the text.
SHARE THIS ARTICLE ON

Related Stories

Over the past two weeks, the daily averages for both coronavirus cases and deaths have dropped by about half in the US, according to data from Johns Hopkins University.(AP)
Over the past two weeks, the daily averages for both coronavirus cases and deaths have dropped by about half in the US, according to data from Johns Hopkins University.(AP)

Experts warn against Covid-19 variants as states reopen in US

AP |
PUBLISHED ON FEB 18, 2021 11:49 PM IST
Scientists widely agree that the US simply doesn’t have enough of a handle on the variants to roll back public health measures and is at risk of fumbling yet another phase of the pandemic after letting the virus rage through the country over the last year and kill nearly 500,000 people.
The US Food and Drug Administration has not yet released a roadmap for how companies should design trials of booster shots(Bloomberg File Photo)
The US Food and Drug Administration has not yet released a roadmap for how companies should design trials of booster shots(Bloomberg File Photo)

Pfizer plans to test Covid-19 vaccine booster made for South African variant

Reuters |
PUBLISHED ON FEB 18, 2021 10:45 PM IST
The company is proposing to do a Phase I clinical trial of a booster shot of that prototype vaccine that it would test against a booster for the current vaccine.
Close
SHARE
Story Saved
OPEN APP